通过生物信息学分析识别具有肺腺癌预后评估价值的关键基因
Yushan Wang1, Ruihong Wang2, Ji Ma3
1School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China. 15866811747@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|September 16, 2023
概括
这项研究确定了十个关键基因,包括LDHA,TRIP13和TTK,这些基因表明肺腺癌 (LUAD) 的预后风险更高. 这些基因的高表达与较短的存活率相关,为LUAD诊断和治疗提供了潜在的点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 过度诊断肺癌导致患者受到伤害和资源浪费.
- 有效的查和肺癌预后风险评估至关重要.
研究的目的:
- 确定用于预测肺腺癌 (LUAD) 预后的关键基因和模块.
- 开发一个预测模型来预测LUAD患者的结果.
- 为了找到用于LUAD诊断和治疗的分子标.
主要方法:
- 从癌症基因组图谱 (TCGA) 中分析LUAD表达特征数据.
- 使用差异表达基因 (DEGs) 构建加权基因共同表达网络.
- 应用LASSO-COX比例风险回归模型用于预后价值评估.
主要成果:
- 确定了与细胞粘附和细胞外基质相关的4107个上调和2022个下调的DEG.
- 已确立的十种基因标记物 (LDHA,TOP2A,UBE2C,TYMS,TRIP13,EXO1,TTK,TPX2,ZWINT,UHRF1) 与预后风险增加有关.
- 在LUAD中LDHA,TRIP13和TTK的高表达与较短的整体存活率相关,并作为独立的预后因素.
结论:
- 已识别的十个基因标记物为LUAD预后提供了宝贵的见解.
- LDHA,TRIP13和TTK是LUAD中潜在的独立预后因素,参与了代谢过程.
- 这项研究为LUAD诊断,治疗和向抑制剂开发提供了分子标.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


